Imre has boosted its well-regarded health practice with the addition of Anna Kotis as president, Imre Health. Most recently managing director at H4B Chelsea, Kotis has led commercial strategy for Pfizer, Forest Laboratories and Mesoblast brands over the course of her 20-year-plus career.

“We’re in the business of developing industry and client firsts through the way we foster innovation with our client partners,” said Imre partner Jeff Smokler in a statement. “As we look to the future, we need a leader like Anna, who offers a 360-degree view of the marketplace and who deeply understands the emerging areas of connection between agency and client.”

“The opportunity to join Imre and make an impact on the agency’s future vision is an exciting one,” Kotis said in the statement. “My passion for healthcare is rooted in developing greater touchpoints with our audiences across a deeper range of digital applications. Marrying this passion with the core equities that has gained Imre success to date will result in complementary, upstream solutions that connect our audiences and brand partners with greater purpose.”

According to MM+M’s 2021 Agency 100, Imre Health generated $24 million in revenue during 2020. That represented a jump of 15% over the year prior.